Up In Smoke: Where Are Potential New Illnesses Tied To Vaping Leading the Cannabis Industry?

In the cannabis industry the CDC recently identified 450 cases of lung disease in people who used vaping products. It indicated that many of the patients suffering from the disease used products containing THC, while others had used a combination of nicotine and THC. On Thursday, September 5, 2019, New York state officials said the illnesses may be related to Vitamin E acetate, but stressed that “No one substance, including Vitamin E acetate, has been identified in all of the samples tested,” according to Stephanie…
Continue reading...

What is THC (Δ-9-Tetrahydrocannabinol)?

Many people associate cannabis with, “getting high” and in part, they are not wrong. The most commonly known active component of Cannabis sativa and Cannabis indica—two of the most common variants of herbal cannabis, is delta-9-tetrahydrocannabinol. In its natural state, THC is not psychoactive! However, this is a slight chemical misnomer—THC in its natural state on the plant is actually THCa or tetrahydrocannabinolic acid. Merely taking a bite out of cannabis plant material should not have an effect on the consumer aside from providing…
Continue reading...

Ketamine: Another Pandora’s Box or Viable Treatment for Pain?

In the wake of the opioid crisis, some physicians are seeking to utilize ketamine, a highly addictive drug, to treat chronic pain and depression. Ketamine is a generic name for Ketalar (ketamine hydrochloride) and belongs to a class of drugs known as dissociate anesthetics. Ketamine’s FDA label warns of the potential emergence of psychological issues with potentially dangerous drug interactions with barbiturates and narcotics. Ketamine has already proven its high potential for abuse and is well-known as a “recreational drug,” “club drug,,” and “date rape…
Continue reading...

DEA Breaks Silence on Marijuana Grower Applications

We previously reported on a unique lawsuit filed this summer by Scottsdale Research Institute, LLC (SRI) against the Drug Enforcement Administration (DEA). By filing a petition for writ of mandamus, SRI sought to compel the DEA to take action on its application to grow cannabis for clinical research, which was filed in 2016. With a deadline to respond to SRI’s petition looming just two days away, the DEA announced on Monday that it is “providing notice of pending applications from entities applying to be…
Continue reading...

DEA Court Ordered to Address Silence on Marijuana Research Applications

In 2016, the Drug Enforcement Administration (DEA) announced that it would be adopting a new policy designed to increase the number of entities that could manufacture marijuana for the use in federally approved research. However, despite receiving at least two dozen applications to grow research marijuana since that announcement, to date the University of Mississippi still holds the only license to manufacture marijuana for research in the United States. Although, that may finally be about to change. Last month, the Scottsdale Research Institute, LLC (SRI)…
Continue reading...

Florida Pill Mills

During the course of the opioid crisis one question remains – who is responsible? Recent litigation and criminal cases have been brought against doctors, pharmaceutical companies, and business executives.  The jury is still out on who is to blame, but one culprit worth reexamining is the involvement of Florida’s pill mill industry. During the 1990s and 2000s, Florida became a hot spot for prescription medications through their unregulated and unchecked pill mills. What is most shocking about the pill mills is that they not only…
Continue reading...

Court Finds That the Plaintiff Lacks Standing in Glyphosate-Related Consumer Class Action Matter

Lawsuits related to glyphosate, including consumer class action claims against food and beverage manufacturers, continue to be filed. In the consumer class action cases, the plaintiffs typically assert that the type of product (e.g., juice, cereals, etc.) had been tested by a laboratory and that trace levels of the pesticide had been detected. In those cases, the plaintiffs are not claiming that they were actually injured by consuming the product. Instead, they are essentially complaining that the product labels are misleading because they do not…
Continue reading...

CBD and Sports: The Intersection Between Science and Performance

There are 123 teams between the four major sports leagues in the United States/Canada. 45 of those teams are located in states or provinces where recreational marijuana is legal. 56 teams are located in jurisdictions where medical marijuana is legal. Overall, 101 out of the 123 professional sports teams between the NBA, NFL, NHL and MLB are located in an area where their employees can legally purchase either medicinal or recreational marijuana. This poses the question: can professional athletes utilize medical or recreational cannabis? For…
Continue reading...

New York and Nevada: A Tale of Two States

As previously reported on Life Science Matters, New York can’t make up its mind when it comes to cannabis legalization. Like Don Corleone said in Godfather III, “Just when I thought I was out…they pull me back in.” Despite a recent “will they or won’t they” dance, proponents of New York’s bill to legalize marijuana for adult use said the bill won’t pass this year. The legislature is still hopeful that a measure expunging criminal records and decriminalizing small amounts of the drug will still…
Continue reading...

Mile High CBD?

It’s not quite what you think, although the concept is somewhat the same — a breakthrough in TSA policy will now allow some cannabidiol (CBD oil) and medications on planes. In April 2019, the Life Science Matters blog wrote about the drug Epidiolex paving the way towards changes in policy and we are now seeing the first tangible result. The Transportation Security Administration modified its cannabis policy to allow flight passengers to bring some forms of CBD oil and FDA approved marijuana based drugs on…
Continue reading...